Synovus Financial Corp Neogenomics Inc Transaction History

Synovus Financial Corp

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$30.49 - $48.49 $159,950 - $254,378	-5,246 Closed	0 $0
Q3 2021 Nov 08, 2021	SELL	$41.66 - $52.52 $326,239 - $411,284	-7,831 Reduced 59.88%	5,246 $243,000
Q2 2021 Aug 11, 2021	SELL	$36.62 - $51.69 $22,777 - $32,151	-622 Reduced 4.54%	13,077 $592,000
Q1 2021 May 11, 2021	SELL	$41.56 - $59.88 $10,764 - $15,508	-259 Reduced 1.86%	13,699 $654,000
Q4 2020 Feb 11, 2021	SELL	$36.08 - $56.47 $83,994 - $131,462	-2,328 Reduced 14.29%	13,958 $757,000
Q3 2020 Nov 09, 2020	BUY	$33.26 - $40.48 $15,399 - $18,742	463 Added 2.93%	16,286 $600,000
Q2 2020 Aug 10, 2020	BUY	$24.21 - $31.02 $95,387 - $122,218	3,940 Added 33.16%	15,823 $490,000
Q1 2020 Apr 24, 2020	SELL	$20.5 - $34.53 $44,751 - $75,378	-2,183 Reduced 15.52%	11,883 $328,000
Q4 2019 Feb 06, 2020	SELL	$18.96 - $29.84 $121,912 - $191,871	-6,430 Reduced 31.37%	14,066 $410,000
Q3 2019 Nov 01, 2019	BUY	$19.12 - $26.24 $391,883 - $537,815	20,496 New	20,496 $393,000

295

125M

698K

120K

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $2.13B
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

Get notified when there are updates to the investment portfolio of Synovus Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Synovus Financial Corp with notifications on news.